Sysorex Global (INPX) Shares Down 15.8%

Sysorex Global (NASDAQ:INPX)’s share price traded down 15.8% on Tuesday . The company traded as low as $0.31 and last traded at $0.32. 2,297,855 shares traded hands during trading, an increase of 97% from the average session volume of 1,164,826 shares. The stock had previously closed at $0.38.

Separately, B. Riley reissued a “neutral” rating and set a $0.25 price objective on shares of Sysorex Global in a report on Tuesday, August 22nd.

The company has a quick ratio of 0.35, a current ratio of 0.31 and a debt-to-equity ratio of -0.13.

ILLEGAL ACTIVITY WARNING: “Sysorex Global (INPX) Shares Down 15.8%” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/23/sysorex-global-inpx-shares-down-15-8.html.

Sysorex Global Company Profile

Inpixon, formerly Sysorex Global, provides data analytics and location-based solutions and services to commercial and government customers across the world. The Company operates through four segments: Mobile, IoT & Big Data Products, which includes its AirPatrol product line and on-premise big data appliance product; Storage and Computing, which includes third-party hardware, software and related maintenance/warranty products and services that the Company resells; SaaS Revenues, which provides software-as-a-services or Internet-based hosted services, and Professional Services, which offers general information technology (IT) services.

What are top analysts saying about Sysorex Global? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sysorex Global and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit